Next-Generation Anti-IL-1α Antibodies

About XBiotech

XBiotech is dedicated to discovering and developing therapeutic antibodies sourced directly from human donors with natural immunity, a platform it calls True Human™. The company has achieved a significant milestone with the $750M sale of an IL-1α antibody and is advancing a pipeline in oncology, neurology, rheumatology, and anti-infectives. With a state-of-the-art manufacturing facility in Austin, Texas, XBiotech aims to create breakthrough therapies with improved safety profiles by leveraging the body's own immune defenses.

Therapeutic Areas